Motives of Dutch men who have sex with men for daily and intermittent HIV pre-exposure prophylaxis usage and preferences for implementation: A qualitative study.
Although PrEP is not yet registered in Europe, including the Netherlands, its approval and implementation are expected in the near future. To inform future pre-exposure prophylaxis (PrEP) implementation, this study aimed to gain insight into motives and preferences for daily or intermittent PrEP use among Dutch HIV-negative men having sex with men (MSM).Between February and December 2013, semistructured interviews were conducted until data saturation was reached (N = 20). Interviews were analyzed using the Grounded Theory approach.Motives for (not) using daily PrEP were based on beliefs about PrEP efficacy and side effects, preferences for other prevention strategies, self-perceived HIV risk, self-perceived efficacy of PrEP adherence, beliefs about possible benefits (e.g., anxiety reduction, sex life improvement), and barriers of PrEP use (e.g., costs, monitoring procedures). The perceived benefits of intermittent versus daily PrEP use were the lower costs and side effects and the lower threshold to decision to start using intermittent PrEP. Barriers of intermittent PrEP versus daily PrEP use were the perceived need to plan their sex life and adhere to multiple prevention strategies. Although some perceived PrEP as a condom substitute, others were likely to combine PrEP and condoms for sexually transmitted infections (STI) prevention and increased HIV protection. Participants preferred PrEP service locations to have specialized knowledge of HIV, antiretroviral therapy, sexual behavior, STIs, patients' medical background, be easily approachable, be able to perform PrEP follow-up monitoring, and provide support.To maximize the public health impact of PrEP, ensuring high uptake among MSM at highest risk is important. Therefore, targeted information about PrEP efficacy and side effects need to be developed, barriers for accessing PrEP services should be minimized, and perceived self-efficacy to use PrEP should be addressed and improved. To prevent increases in STIs, condom use should be monitored and PrEP should be integrated into routine STI screening and counseling.
aDepartment of Infectious Diseases Research and Prevention, Public Health Service Amsterdam, Amsterdam, the Netherlands bDepartment of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunology Amsterdam (CINIMA), Academic Medical Center (AMC), University of Amsterdam, Amsterdam, the Netherlands.
Janneke P
JP
Bil
Wendy M
WM
van der Veldt
Maria
M
Prins
Ineke G
IG
Stolte
Udi
U
Davidovich
D000328:Adult; D017280:Condoms; D015658:HIV Infections / Q000517:prevention & control / Q000523:psychology*; D018451:Homosexuality, Male / Q000523:psychology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009042:Motivation; D009426:Netherlands; D010342:Patient Acceptance of Health Care / Q000523:psychology; D065129:Pre-Exposure Prophylaxis / Q000379:methods / Q000706:statistics & numerical data*; D036301:Qualitative Research; D012747:Sexual Partners / Q000523:psychology; D000072339:Sexual and Gender Minorities / Q000523:psychology*; D012749:Sexually Transmitted Diseases / Q000517:prevention & control / Q000523:psychology*
AIDS. 2011 Feb 20;25(4):493-501
21192230
Lancet Infect Dis. 2014 Sep;14(9):820-9
25065857
Lancet. 2016 Jan 2;387(10013):53-60
26364263
Ann Intern Med. 2012 Apr 17;156(8):541-50
22508731
PLoS One. 2013;8(1):e54288
23342121
Lancet. 2012 Jul 28;380(9839):367-77
22819660
Ann Behav Med. 2015 Apr;49(2):177-86
25124457
AIDS. 2008 Sep 12;22(14):1829-39
18753932
N Engl J Med. 2000 Mar 30;342(13):921-9
10738050
BMJ. 1989 Jan 28;298(6668):218-21
2493866
PLoS Med. 2013;10(3):e1001401
23554579
Clin Infect Dis. 2015 Nov 15;61(10 ):1601-3
26334052
Curr Opin HIV AIDS. 2016 Jan;11(1):56-66
26569182
N Engl J Med. 2011 Aug 11;365(6):493-505
21767103
N Engl J Med. 2010 Dec 30;363(27):2587-99
21091279
N Engl J Med. 2015 Dec 3;373(23):2237-46
26624850
AIDS Patient Care STDS. 2012 Feb;26(2):87-94
22149764
AIDS. 2015 May 15;29(8):955-64
25915169
AIDS Patient Care STDS. 2013 Apr;27(4):248-54
23565928
Clin Infect Dis. 2014 Apr;58(7):1027-34
24385445
AIDS Care. 2011 Sep;23(9):1136-45
21476147
Implement Sci. 2012 Nov 26;7:116
23181780
Int J STD AIDS. 2011 May;22(5):256-62
21571973